Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEmory University
About this trial
This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.
Eligibility criteria
Qualifiers
Male or Female
Candidate with skin lesions
Signed study-specific informed consent prior to study entry
≥ 18 years old
Disqualifiers
Prior surgery or radiotherapy to the area to be treated
Trial design
Treatments tested in this trial
- Quantitative Oblique Back-Illumination Microscopy
- Radiation Therapy
Treatment groups
10 Participants
are divided into 2 treatment groupsSponsors and collaborators
Emory University
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov